About Index Trending news
Analyze
Pricing
Synoste Oy

Synoste Oy

Work at Synoste Oy? Add yourself to this profile

Synoste Oy

Synoste develops next-generation medical solutions for the treatment and correction of skeletal deformities. Its implants for lengthening limbs are based on a mechanism using smart metals that operate safely and painlessly for the patient.
Edit Profile
More info

Elsewhere

Companies in the same industry

PUSH PUSH intelligentm intelligentm OrthoSensor, Inc. OrthoSensor, Inc. 네오펙트 네오펙트 Ostom-i Ostom-i Noho Noho Lantos Technologies Lantos Technologies Avomeen Analytical Avomeen Analytical Profusa Profusa NeoTract NeoTract

Alexa global traffic share

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2
Add info
Add round
21 Jan 2016
Venture capital
Evonik Venture Capital GmbH

Venture Capital: Evonik invests in SYNOSTE, a medical technology start-up in Düsseldorf and Helsinki Industries - Specialty Chemicals

evonik
06 May 2015
$2,200,000
Venture capital (Series A)
Finnvera Venture Capital, Lifeline Ventures, High-Tech Grunderfonds, +3

Synoste Oy raises € 2.2 M in the first closing of A-round financing to acquire CE-approval for a next generation implant for correcting skeletal deformities

High-Tech Gründerfonds